Probiotic Intervention for Occasional Constipation

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The goal of this clinical trial is to study the effect of probiotics on gut function in subjects with occasional constipation. The main question it aim to answer is if intake of probiotics will decrease the transit time. Participants will randomized to either consume probiotics or a placebo product.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04083521` - Effect of Bacillus Subtilis DE111® on Daily Bowel Movements	N/A
	Completed	`NCT02423564` - A Study Investigating the Effect of Digesta-Lac in Healthy Adults With Occasional Constipation	Phase 2

NCT number	NCT06444139
Study type	Interventional
Source	Probi AB
Contact	Nisrine Zakaria
Phone	12262424559
Email	nzakaria@kgkscience.com
Status	Not yet recruiting
Phase	N/A
Start date	June 2024
Completion date	July 2025

Probiotic Intervention for Occasional Constipation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms